Sharon Barrans

5.0k total citations · 1 hit paper
54 papers, 2.3k citations indexed

About

Sharon Barrans is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Sharon Barrans has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 25 papers in Oncology and 18 papers in Genetics. Recurrent topics in Sharon Barrans's work include Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Viral-associated cancers and disorders (11 papers). Sharon Barrans is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Viral-associated cancers and disorders (11 papers). Sharon Barrans collaborates with scholars based in United Kingdom, Switzerland and Netherlands. Sharon Barrans's co-authors include Andrew Jack, Roger G. Owen, Russell Patmore, Gareth J. Morgan, Simon Crouch, Eve Roman, Alex Smith, Andrew Haynes, Paul Evans and Faith E. Davies and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sharon Barrans

50 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

2020 260 citations Stuart Lacy, Sharon Barrans et al. Blood profile →

Peers

Countries citing papers authored by Sharon Barrans

Since Specialization

Citations

This map shows the geographic impact of Sharon Barrans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Barrans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Barrans more than expected).

Fields of papers citing papers by Sharon Barrans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Barrans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Barrans. The network helps show where Sharon Barrans may publish in the future.

Co-authorship network of co-authors of Sharon Barrans

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Barrans. A scholar is included among the top collaborators of Sharon Barrans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Barrans. Sharon Barrans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK’s Haematological Malignancy Research Network 2023 ·Cancer Epidemiology ·Maxine Lamb, Daniel Painter, Debra Howell, Sharon Barrans, Catherine Cargo, Ruth de Tute, Reuben Tooze, Cathy Burton, Russell Patmore, Eve Roman, Alexandra Smith	10
2	Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network 2022 ·Blood Advances ·Simon Crouch, Daniel Painter, Sharon Barrans, Eve Roman, Philip Beer, Susanna L. Cooke, Paul Glover, (unknown), Nichola Webster, Stuart Lacy, Camilo Ruiz, Peter J. Campbell, Daniel J. Hodson, Russell Patmore, Cathy Burton, Alexandra Smith, Reuben Tooze	17
3	Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report breakdown → 2020 ·Blood ·Stuart Lacy, Sharon Barrans, Philip Beer, Daniel Painter, Alexandra Smith, Eve Roman, Susanna L. Cooke, Camilo Ruiz, Paul Glover, (unknown), Nichola Webster, Peter J. Campbell, Reuben Tooze, Russell Patmore, Cathy Burton, Simon Crouch, Daniel J. Hodson	260
4	Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial 2020 ·SHILAP Revista de lepidopterología ·Elizabeth H. Phillips, Catherine Burton, Amy A. Kirkwood, Sharon Barrans, (unknown), Simon Rule, Russell Patmore, Ruth Pettengell, Kirit M. Ardeshna, Silvia Montoto, Shankara Paneesha, Laura Clifton‐Hadley, David C. Linch, Andrew McMillan	6
5	Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance 2020 ·British Journal of Haematology ·(unknown), Paul Glover, (unknown), Chulin Sha, Matthew A. Care, Reuben Tooze, Andrew Davies, David R. Westhead, Peter Johnson, Catherine Burton, Sharon Barrans	6
6	N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells 2016 ·Haematologica ·Philip J. Brown, (unknown), Linden Lyne, Hayley Spearman, Suet Ling Felce, N McFadden, Probir Chakravarty, Sharon Barrans, Steven Lynham, Dinis Pedro Calado, Malcolm Ward, Alison H. Banham	7
7	Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas 2015 ·Genome Medicine ·Chulin Sha, Sharon Barrans, Matthew A. Care, David Cunningham, Reuben Tooze, Andrew Jack, David R. Westhead	18
8	Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing 2015 ·Journal of Molecular Diagnostics ·Ming Wang, Leire Escudero‐Ibarz, Sarah Moody, Naiyan Zeng, Alexandra Clipson, Yuanxue Huang, Xuemin Xue, Nicholas F. Grigoropoulos, Sharon Barrans, Lisa Worrillow, Tim Forshew, Jing Su, Andrew E. Firth, Howard Martin, Andrew Jack, Kim Brügger, Ming‐Qing Du	18
9	SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity 2014 ·Nucleic Acids Research ·Matthew A. Care, Mario Cocco, (unknown), Nicholas A. Barnes, Yuanxue Huang, Ming Wang, Sharon Barrans, Ming‐Qing Du, Andrew Jack, David R. Westhead, Gina M. Doody, Reuben Tooze	33
10	Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab 2010 ·Journal of Clinical Oncology ·Sharon Barrans, Simon Crouch, Alex Smith, Kathryn Turner, Roger G. Owen, Russell Patmore, Eve Roman, Andrew Jack	402
11	Expression pattern of XBP1(S) in human B-cell lymphomas 2009 ·Haematologica ·Lorena Maestre, Reuben Tooze, Marta Cañamero, Santiago Montes‐Moreno, (unknown), Gina M. Doody, M. Boll, Sharon Barrans, (unknown), Miguel Á. Piris, Giovanna Roncador	25
12	Demonstration of a Germinal Center Immunophenotype in Lymphomas by Immunocytochemistry and Flow Cytometry 2005 ·PubMed ·Andrew Jack, Sharon Barrans, David Blythe, Andy C. Rawstron	4
13	Recent advances in the understanding of aggressive B-cell lymphomas 2004 ·Current Diagnostic Pathology ·Andrew Jack, Sharon Barrans	3
14	The Detection of t(14;18) in Archival Lymph Nodes 2003 ·Journal of Molecular Diagnostics ·Sharon Barrans, Paul Evans, Sheila J.M. O’Connor, Roger G. Owen, Gareth J. Morgan, Andrew Jack	38
15	Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation 2003 ·Seminars in Oncology ·Derek Leitch, Sharon Barrans, Andrew Jack, Roger G. Owen	5
16	Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B‐cell lymphoma 2002 ·British Journal of Haematology ·Sharon Barrans, Sheila J.M. O’Connor, Paul Evans, Faith E. Davies, Roger G. Owen, Andrew Haynes, Gareth J. Morgan, Andrew Jack	96
17	In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA‐5 and CD45 expression 2001 ·British Journal of Haematology ·Andy C. Rawstron, Sharon Barrans, David Blythe, (unknown), Stephen J. Richards, James A. L. Fenton, Faith E. Davies, J. A. Child, Andrew Jack, Gareth J. Morgan	20
18	Waldenström Macroglobulinemia 2001 ·American Journal of Clinical Pathology ·Roger G. Owen, Sharon Barrans, Stephen J. Richards, Sheila J.M. O’Connor, J. A. Child, L. A. Parapia, Gareth J. Morgan, Andrew Jack	101
19	Microsatellite instability in follicle centre cell lymphoma 1996 ·British Journal of Haematology ·Juliette A. Randerson‐Moor, Lynn Cawkwell, Andrew Jack, J. A. Child, (unknown), (unknown), Peter Johnson, Paul Evans, Sharon Barrans, Gareth J. Morgan	16
20	Fluorescent polymerase chain reaction of a panel of CA repeats on chromosome 6 in the indolent phase of follicular centre cell lymphoma 1996 ·British Journal of Cancer ·Juliette A. Randerson‐Moor, Lynn Cawkwell, Andrew Jack, (unknown), Patrick Johnson, Paul Evans, Sharon Barrans, Gareth J. Morgan	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact